Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 435

1.

Development of a Novel Computerized Clinical Decision Support System to Improve Adolescent Sexual Health Care Provision.

Miller MK, Mollen C, Behr K, Dowd MD, Miller E, Satterwhite CL, Stancil S, Allen N, Michael J, Inboriboon PC, Park A, Goggin K.

Acad Emerg Med. 2018 Sep 21. doi: 10.1111/acem.13570. [Epub ahead of print]

PMID:
30240032
2.

A-Kinase Anchoring Protein 13 (AKAP13) Augments Progesterone Signaling in Uterine Fibroid Cells.

Ng SSM, Jorge S, Malik M, Britten J, Su SC, Armstrong CR, Brennan JT, Chang S, Baig KM, Driggers PH, Segars JH.

J Clin Endocrinol Metab. 2018 Sep 14. doi: 10.1210/jc.2018-01216. [Epub ahead of print]

PMID:
30239831
3.

State of emergency contraception in the U.S., 2018.

Haeger KO, Lamme J, Cleland K.

Contracept Reprod Med. 2018 Sep 5;3:20. doi: 10.1186/s40834-018-0067-8. eCollection 2018. Review.

4.

Liver injury and ulipristal acetate: an overstated tragedy?

Donnez J.

Fertil Steril. 2018 Sep;110(4):593-595. doi: 10.1016/j.fertnstert.2018.06.044. No abstract available.

PMID:
30196943
5.

Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users: A Randomized Controlled Trial.

Zigler RE, Madden T, Ashby C, Wan L, McNicholas C.

Obstet Gynecol. 2018 Aug 17. doi: 10.1097/AOG.0000000000002810. [Epub ahead of print]

PMID:
30130351
6.

Combined oral contraceptive interference with the ability of ulipristal acetate to delay ovulation: A prospective cohort study.

Edelman AB, Jensen JT, McCrimmon S, Messerle-Forbes M, O'Donnell A, Hennebold JD.

Contraception. 2018 Aug 14. pii: S0010-7824(18)30396-2. doi: 10.1016/j.contraception.2018.08.003. [Epub ahead of print]

PMID:
30118684
7.

Pregnancy Outcomes Following Ulipristal Acetate for Uterine Fibroids: A Systematic Review.

De Gasperis-Brigante C, Singh SS, Vilos G, Kives S, Murji A.

J Obstet Gynaecol Can. 2018 Aug;40(8):1066-1076.e2. doi: 10.1016/j.jogc.2018.05.020. Review.

PMID:
30103881
8.

Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports.

Santoro A, Angelico G, Arciuolo D, Inzani F, Fanfani F, Romualdi D, Scambia G, Zannoni GF.

Medicine (Baltimore). 2018 Aug;97(31):e11532. doi: 10.1097/MD.0000000000011532.

9.

Insights into the interaction of ulipristal acetate and human serum albumin using multi-spectroscopic methods, molecular docking, and dynamic simulation.

Gan N, Sun Q, Zhang M, Tang P, Zhao L, Xie T, Zhang Y, Li H.

J Biomol Struct Dyn. 2018 Jul 30:1-24. doi: 10.1080/07391102.2018.1502686. [Epub ahead of print]

PMID:
30056779
10.

Ulipristal acetate induces cell cycle delay and remodeling of extracellular matrix.

Shin SJ, Kim J, Lee S, Baek J, Lee JE, Cho C, Ha E.

Int J Mol Med. 2018 Oct;42(4):1857-1864. doi: 10.3892/ijmm.2018.3779. Epub 2018 Jul 17.

11.

Ulipristal Acetate Interferes With Actin Remodeling Induced by 17β-Estradiol and Progesterone in Human Endometrial Stromal Cells.

Shortrede JE, Montt-Guevara MM, Pennacchio G, Finiguerra M, Giannini A, Genazzani AD, Simoncini T.

Front Endocrinol (Lausanne). 2018 Jun 27;9:350. doi: 10.3389/fendo.2018.00350. eCollection 2018.

12.

Ulipristal.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

13.

Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial.

Illingworth BJG, Hirsch M, Duffy JMN.

Obstet Gynecol. 2018 Jul;132(1):215. doi: 10.1097/AOG.0000000000002718. No abstract available.

PMID:
29939915
14.

Changes in sexuality during ulipristal acetate treatment in women with symptomatic uterine fibroids.

Tuschy B, Gabbert M, Weiss C, Hornemann A, Wuhrer A, Sütterlin M, Berlit S.

Eur J Obstet Gynecol Reprod Biol. 2018 Sep;228:106-110. doi: 10.1016/j.ejogrb.2018.06.027. Epub 2018 Jun 17.

PMID:
29920429
15.

Model for Hormonal Emergency Contraception (HEC) in cycling and mated guinea pigs - Studies with the Progesterone Receptor Modulators (PRM) Ulipristal Acetate (UPA/CDB2914) and EC317.

Elger W, Schneider B, Killeen Z, Jewgenow K, Dehnhard M, Friedrich M, Santhamma B, Wedemeyer R, Nickisch K.

J Steroid Biochem Mol Biol. 2018 Oct;183:152-158. doi: 10.1016/j.jsbmb.2018.06.009. Epub 2018 Jun 11.

PMID:
29902513
16.

Progesterone Autoimmune Dermatitis Responding to Ulipristal Acetate.

Oscoz-Jaime S, Larrea-García M, Mitxelena-Eceiza MJ, Abián-Franco N.

Actas Dermosifiliogr. 2018 May 31. pii: S0001-7310(18)30088-7. doi: 10.1016/j.ad.2017.11.016. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
29861040
17.
18.

Gene expression changes in uterine myomas in response to ulipristal acetate treatment.

Courtoy GE, Donnez J, Ambroise J, Arriagada P, Luyckx M, Marbaix E, Dolmans MM.

Reprod Biomed Online. 2018 Aug;37(2):224-233. doi: 10.1016/j.rbmo.2018.04.050. Epub 2018 May 7.

PMID:
29807764
19.

The politics of place: Presidential voting patterns and providers' prescription of emergency contraception.

Cleland K, Wagner B, Batur P, McNamara M, Wu J, Rothberg MB.

Contraception. 2018 Sep;98(3):237-242. doi: 10.1016/j.contraception.2018.05.013. Epub 2018 May 18.

PMID:
29778587
20.

Emergency contraception supply in Australian pharmacies after the introduction of ulipristal acetate: a mystery shopping mixed-methods study.

Collins JC, Schneider CR, Moles RJ.

Contraception. 2018 Sep;98(3):243-246. doi: 10.1016/j.contraception.2018.04.020. Epub 2018 May 9.

PMID:
29752924

Supplemental Content

Loading ...
Support Center